PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9122357-7	1997	Recent research in nonhuman primates has characterized the behavioral, respiratory and cardiovascular effects of a number of xanthines and related drugs differing in affinity at different subtypes of adenosine receptors and in capacity to inhibit different molecular forms of PDE.	Xanthines	125-134	aldehyde dehydrogenase 7 family member A1	Homo sapiens	276-279	
9122357-8	1997	The behavioral-stimulant effects of xanthines appear to be mediated principally by their adenosine-antagonist actions and may be limited by PDE inhibition.	Xanthines	36-45	aldehyde dehydrogenase 7 family member A1	Homo sapiens	140-143	
9122357-9	1997	The respiratory-stimulant and cardiac effects of xanthines, on the other hand, appear to be linked more closely to their PDE-inhibiting actions than to adenosine antagonism.	Xanthines	49-58	aldehyde dehydrogenase 7 family member A1	Homo sapiens	121-124	
9122357-10	1997	Converging lines of evidence suggest that adenosine A2 and cAMP-specific (possibly type IV) PDE mechanisms play especially prominent roles in mediating the behavioral and physiological effects of xanthines in nonhuman primates.	Xanthines	196-205	aldehyde dehydrogenase 7 family member A1	Homo sapiens	92-95